Gujarat Terce Laboratories Ltd
₹38.36
(-3.28%)
Wed, 04 Mar 2026, 05:44 am
Health Technology
Pharmaceuticals: Major
24.5KGujarat Terce Laboratories Enterprise Value (EV)
| Particulars | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 143.79 | 46.23 | 28.94 | 69.89 | 43.33 | 22.69 | 52.20 | 0 | 0 | 32.78 | 15.61 | 17.01 | 0 | 22.24 | 0 | 161.43 | 0 |
| Price to book ratio | 0.71 | 1.01 | 1.15 | 0.87 | 0.77 | 0.50 | 0.43 | 0.51 | 1.02 | 0.85 | 0.62 | 0.42 | 0.67 | 2.27 | 1.80 | 5.53 | 7 |
| Price to sales ratio | 0.26 | 0.34 | 0.34 | 0.09 | 0.10 | 0.19 | 0.18 | 0.21 | 0.40 | 0.30 | 0.22 | 0.13 | 0.21 | 0.48 | 0.26 | 0.82 | 0.90 |
| Price to cash flow ratio | 0 | 21.73 | 6.49 | 0 | 2.28 | 39.06 | 4.73 | 0 | 28.77 | 1.91 | 0 | 0 | 0 | 0 | 0 | 17.64 | 15.65 |
| Enterprise value | 70.1M | 86.55M | 129.1M | 190.93M | 155.96M | 130.62M | 111.12M | 119.11M | 166.63M | 83.92M | 72.51M | 72.51M | 86.15M | 245.67M | 176.05M | 430.67M | 445.19M |
| Enterprise value to EBITDA ratio | 11.01 | 40.83 | 9.58 | 40.29 | 50.11 | 13.64 | 12.12 | 72.76 | 187.58 | 25.26 | 14.62 | 10.38 | 0 | 21.74 | 0 | 32.99 | 11.34 |
| Debt to equity ratio | 0.58 | 0.52 | 0.32 | 1.01 | 0.85 | 0.80 | 0.75 | 0.69 | 0.70 | 0.04 | 0.06 | 0.23 | 0.62 | 0.78 | 1.06 | 0.54 | 0.15 |
| Return on equity % | 0 | 2.22 | 5.08 | 1.25 | 1.79 | 2.23 | 0.83 | -6.33 | -0.15 | 2.66 | 4.08 | 2.52 | -26.85 | 10.77 | -21.71 | 3.48 | -14.41 |
Gujarat Terce Laboratories Ltd Enterprise Value
The Gujarat Terce Laboratories Ltd Enterprise Value is a key financial metric used by investors to evaluate Gujarat Terce Laboratories Ltd's valuation, profitability, and overall financial performance. Tracking the Gujarat Terce Laboratories Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Gujarat Terce Laboratories Ltd (NSE: , BSE: 524314) is currently trading at ₹38.36, with a market capitalization of ₹298.87M. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Gujarat Terce Laboratories Ltd Enterprise Value is essential for fundamental analysis.
Gujarat Terce Laboratories Ltd Enterprise Value Current Value
The current Gujarat Terce Laboratories Ltd Enterprise Value stands at 445.19M.
The latest Gujarat Terce Laboratories Ltd Enterprise Value has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Gujarat Terce Laboratories Ltd Enterprise Value Historical Trend
The Gujarat Terce Laboratories Ltd Enterprise Value has shown the following historical trend:
- 2024: 445.19M
- 2023: 430.67M
- 2022: 176.05M
- 2021: 245.67M
- 2020: 86.15M
The recent rise in Gujarat Terce Laboratories Ltd Enterprise Value suggests strengthening valuation trends and improving market sentiment.
What Gujarat Terce Laboratories Ltd Enterprise Value Indicates for Investors
The Gujarat Terce Laboratories Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Gujarat Terce Laboratories Ltd.
Gujarat Terce Laboratories Ltd Enterprise Value Analysis Summary
The Gujarat Terce Laboratories Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Gujarat Terce Laboratories Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Gujarat Terce Laboratories Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800